Cargando…
ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells
Cancer is a multifactorial and deadly disease. Despite major advancements in cancer therapy in the last two decades, cancer incidence is on the rise and disease prognosis still remains poor. Furthermore, molecular mechanisms of cancer invasiveness, metastasis, and drug resistance remain largely elus...
Autores principales: | Jung, Bo-Kyeong, Kim, Young Jun, Hong, JinWoo, Chang, Han-Gyu, Yoon, A-Rum, Yun, Chae-Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266575/ https://www.ncbi.nlm.nih.gov/pubmed/35806132 http://dx.doi.org/10.3390/ijms23137127 |
Ejemplares similares
-
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses
por: Thambi, Thavasyappan, et al.
Publicado: (2022) -
A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth
por: Yoon, A-Rum, et al.
Publicado: (2015) -
Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions
por: Yoon, A-Rum, et al.
Publicado: (2018) -
Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosis
por: Yoon, A-Rum, et al.
Publicado: (2017) -
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
por: Yun, Chae-Ok, et al.
Publicado: (2022)